150 related articles for article (PubMed ID: 3947650)
41. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
Pletcher CH; Cunningham M; Nelsestuen GL
Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
[TBL] [Abstract][Full Text] [Related]
42. The role of Arg46 and Arg47 of antithrombin in heparin binding.
Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
[TBL] [Abstract][Full Text] [Related]
43. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
[TBL] [Abstract][Full Text] [Related]
44. Antithrombin reactions with alpha- and gamma-thrombins.
Chang T; Feinman RD; Landis BH; Fenton JW
Biochemistry; 1979 Jan; 18(1):113-9. PubMed ID: 420768
[TBL] [Abstract][Full Text] [Related]
45. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
[TBL] [Abstract][Full Text] [Related]
46. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.
Griffith MJ
J Biol Chem; 1982 Jul; 257(13):7360-5. PubMed ID: 7085630
[No Abstract] [Full Text] [Related]
47. Activity toward thrombin-antithrombin of heparin immobilized on two hydrogels.
Tay SW; Merrill EW; Salzman EW; Lindon J
Biomaterials; 1989 Jan; 10(1):11-5. PubMed ID: 2713428
[TBL] [Abstract][Full Text] [Related]
48. Heparin-sensitive and nonsensitive forms of thrombin.
Machovich R
Biochim Biophys Acta; 1975 Jul; 400(1):62-8. PubMed ID: 1170899
[TBL] [Abstract][Full Text] [Related]
49. Mechanism of action of heparin through thrombin on blood coagulation.
Machovich R
Biochim Biophys Acta; 1975 Nov; 412(1):13-7. PubMed ID: 1191673
[TBL] [Abstract][Full Text] [Related]
50. Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.
Olson ST; Björk I; Shore JD
Methods Enzymol; 1993; 222():525-59. PubMed ID: 8412815
[No Abstract] [Full Text] [Related]
51. Inhibition of fibrin-bound thrombin by a covalent antithrombin-heparin complex.
Berry LR; Becker DL; Chan AK
J Biochem; 2002 Aug; 132(2):167-76. PubMed ID: 12153711
[TBL] [Abstract][Full Text] [Related]
52. Sulfated galactan is a catalyst of antithrombin-mediated inactivation of alpha-thrombin.
Melo FR; Pereira MS; Monteiro RQ; Foguel D; Mourão PA
Biochim Biophys Acta; 2008 Sep; 1780(9):1047-53. PubMed ID: 18558097
[TBL] [Abstract][Full Text] [Related]
53. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. The reaction step limiting heparin turnover in thrombin neutralization.
Olson ST; Shore JD
J Biol Chem; 1986 Oct; 261(28):13151-9. PubMed ID: 3759953
[TBL] [Abstract][Full Text] [Related]
54. Differences in the effect of antithrombin on thrombin clotting and thrombin esterase activity.
Gans H; Boulton A
Thromb Diath Haemorrh; 1969 Aug; 22(1):28-31. PubMed ID: 5821245
[No Abstract] [Full Text] [Related]
55. Antithrombin III: a backward glance o'er travel'd roads.
Seegers WH
Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
[TBL] [Abstract][Full Text] [Related]
56. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
[TBL] [Abstract][Full Text] [Related]
57. Interaction and thermal stability of fluorescent labeled derivatives of thrombin and antithrombin III.
Atha DH; Brew SA; Ingham KC
Biochim Biophys Acta; 1984 Feb; 785(1-2):1-6. PubMed ID: 6696918
[TBL] [Abstract][Full Text] [Related]
58. Adverse effect of heparin in thrombin-antithrombin III interaction.
Marciniak E
Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
[TBL] [Abstract][Full Text] [Related]
59. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
60. On the reliability of the use of heparin immobilized on agarose for the study of the interactions among heparin, thrombin and antithrombin.
Fish WW; Björk I
Thromb Haemost; 1982 Aug; 48(1):84-6. PubMed ID: 7135347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
